Works matching IS 19466234 AND DT 2017 AND VI 9 AND IP 401

Results: 7
    1
    2
    3
    4
    5

    Synergistic action of the MCL-1 inhibitor S63845 with current therapies in preclinical models of triple-negative and HER2-amplified breast cancer.

    Published in:
    Science Translational Medicine, 2017, v. 9, n. 401, p. 1, doi. 10.1126/scitranslmed.aam7049
    By:
    • Merino, Delphine;
    • Whittle, James R.;
    • Vaillant, François;
    • Serrano, Antonin;
    • Jia-Nan Gong;
    • Giner, Goknur;
    • Maragno, Ana Leticia;
    • Chanrion, Maïa;
    • Schneider, Emilie;
    • Bhupinder Pal;
    • Xiang Li;
    • Dewson, Grant;
    • Gräsel, Julius;
    • Liu, Kevin;
    • Lalaoui, Najoua;
    • Segal, David;
    • Herold, Marco J.;
    • Huang, David C. S.;
    • Smyth, Gordon K.;
    • Geneste, Olivier
    Publication type:
    Article
    6

    A phenotypically and functionally distinct human T<sub>H</sub>2 cell subpopulation is associated with allergic disorders.

    Published in:
    Science Translational Medicine, 2017, v. 9, n. 401, p. 1, doi. 10.1126/scitranslmed.aam9171
    By:
    • Wambre, Erik;
    • Bajzik, Veronique;
    • DeLong, Jonathan H.;
    • O'Brien, Kimberly;
    • Quynh-Anh Nguyen;
    • Speake, Cate;
    • Gersuk, Vivian H.;
    • DeBerg, Hannah A.;
    • Whalen, Elizabeth;
    • Ni, Chester;
    • Farrington, Mary;
    • Jeong, David;
    • Robinson, David;
    • Linsley, Peter S.;
    • Vickery, Brian P.;
    • Kwok, William W.
    Publication type:
    Article
    7